Insight Molecular Diagnostics Inc.
Diagnostics company · Nashville, Tennessee, United States · Nasdaq: IMDX
Insight Molecular Diagnostics Inc. is a diagnostics company headquartered in Nashville, Tennessee, United States. Its shares trade on Nasdaq under the ticker IMDX. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2025.
Insight Molecular Diagnostics at a glance
What does Insight Molecular Diagnostics do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $21.7 million sold (2025).
Frequently asked questions about Insight Molecular Diagnostics
Where is Insight Molecular Diagnostics headquartered?
Insight Molecular Diagnostics Inc. is headquartered in Nashville, Tennessee, United States.
What does Insight Molecular Diagnostics do?
Insight Molecular Diagnostics Inc. is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Insight Molecular Diagnostics a public company?
Yes. Insight Molecular Diagnostics Inc. trades on Nasdaq under the ticker IMDX.
Similar companies
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Lucira Health, Inc.Emeryville, California, United States
- NeuroTrack Technologies, Inc.Redwood City, California, United States
- Biomerica IncIrvine, California, United States
- Meridian Bioscience IncCincinnati, Ohio, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.